Jasmin Tiro to Middle Aged
This is a "connection" page, showing publications Jasmin Tiro has written about Middle Aged.
Connection Strength
1.541
-
Unmet Needs and Receipt of Supportive Care Services in Head and Neck Cancer Patients Prior to Oncologic Treatment: A Prospective, Cross-Sectional Pilot Study. Ann Otol Rhinol Laryngol. 2023 Nov; 132(11):1361-1372.
Score: 0.060
-
Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study. Cancer Prev Res (Phila). 2023 03 01; 16(3):127-132.
Score: 0.060
-
Population-based correlates of COVID-19 infection: An analysis from the DFW COVID-19 prevalence study. PLoS One. 2022; 17(12):e0278335.
Score: 0.059
-
The impact of intimate partner violence on breast and cervical cancer survivors in an integrated, safety-net setting. J Cancer Surviv. 2020 12; 14(6):906-914.
Score: 0.050
-
Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
Score: 0.048
-
Emergency Department Testing Patterns for Sexually Transmitted Diseases in North Texas. Sex Transm Dis. 2019 07; 46(7):434-439.
Score: 0.046
-
Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result. J Womens Health (Larchmt). 2019 03; 28(3):384-392.
Score: 0.044
-
Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1398-1406.
Score: 0.044
-
Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS. 2018 08 24; 32(13):1861-1870.
Score: 0.044
-
Effects of program scale-up on time to resolution for patients with abnormal screening mammography results. Cancer Causes Control. 2018 Oct; 29(10):995-1005.
Score: 0.044
-
Reducing "I Don't Know" Responses and Missing Survey Data: Implications for Measurement. Med Decis Making. 2018 08; 38(6):673-682.
Score: 0.043
-
Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System. J Clin Gastroenterol. 2017 Aug; 51(7):650-655.
Score: 0.040
-
County-level outcomes of a rural breast cancer screening outreach strategy: a decentralized hub-and-spoke model (BSPAN2). Transl Behav Med. 2017 06; 7(2):349-357.
Score: 0.040
-
Translating self-persuasion into an adolescent HPV vaccine promotion intervention for parents attending safety-net clinics. Patient Educ Couns. 2017 04; 100(4):736-741.
Score: 0.039
-
Modification and validation of the Treatment Self Regulation Questionnaire to assess parental motivation for HPV vaccination of adolescents. Vaccine. 2016 09 22; 34(41):4985-4990.
Score: 0.038
-
Validity of Single-Item Screening for Limited Health Literacy in English and Spanish Speakers. Am J Public Health. 2016 May; 106(5):889-92.
Score: 0.037
-
Assessing race and ethnicity data quality across cancer registries and EMRs in two hospitals. J Am Med Inform Assoc. 2016 05; 23(3):627-34.
Score: 0.036
-
Validation of self-reported post-treatment mammography surveillance among breast cancer survivors by electronic medical record extraction method. Breast Cancer Res Treat. 2015 Jun; 151(2):427-34.
Score: 0.035
-
Does language moderate the influence of information scanning and seeking on HPV knowledge and vaccine awareness and initiation among Hispanics? Ethn Dis. 2013; 23(1):95-102.
Score: 0.029
-
Understanding how mothers of adolescent girls obtain information about the human papillomavirus vaccine: associations between mothers' health beliefs, information seeking, and vaccination intentions in an ethnically diverse sample. J Health Psychol. 2013 Jul; 18(7):926-38.
Score: 0.029
-
Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila). 2012 Sep; 5(9):1124-30.
Score: 0.029
-
Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. J Womens Health (Larchmt). 2012 Jun; 21(6):656-65.
Score: 0.028
-
Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine. 2011 Jun 06; 29(25):4238-43.
Score: 0.026
-
What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):288-94.
Score: 0.020
-
Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2855-61.
Score: 0.018
-
Validation of scales measuring attitudes and norms related to mammography screening in women veterans. Health Psychol. 2005 Nov; 24(6):555-66.
Score: 0.018
-
Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial. JAMA. 2023 11 28; 330(20):1971-1981.
Score: 0.016
-
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
Score: 0.015
-
Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care. Contraception. 2023 06; 122:109993.
Score: 0.015
-
Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 Nov 01; 5(11):e2244343.
Score: 0.015
-
Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
Score: 0.015
-
Long-term Mammography Adherence among Uninsured Women Enrolled in the Breast Screening and Patient Navigation (BSPAN) Program. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):77-84.
Score: 0.014
-
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871.
Score: 0.014
-
Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual. Med Care. 2021 05 01; 59(5):461-466.
Score: 0.013
-
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Front Immunol. 2021; 12:624230.
Score: 0.013
-
Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV. J Low Genit Tract Dis. 2021 Jan 01; 25(1):43-47.
Score: 0.013
-
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system. Prev Med. 2021 04; 145:106410.
Score: 0.013
-
Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2020 08; 52(4):701-709.
Score: 0.012
-
Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma. PLoS One. 2020; 15(3):e0229569.
Score: 0.012
-
Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits. J Med Screen. 2020 09; 27(3):146-156.
Score: 0.012
-
Evaluating the Validity of the Risk Perception Survey for Developing Diabetes Scale in a Safety-Net Clinic Population of English and Spanish Speakers. Diabetes Educ. 2020 02; 46(1):73-82.
Score: 0.012
-
Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial. JAMA Netw Open. 2019 11 01; 2(11):e1914729.
Score: 0.012
-
Understanding Underuse of Advance Care Planning Among a Cohort of African American Patients With Advanced Cancer: Formative Research That Examines Gaps in Intent to Discuss Options for Care. Am J Hosp Palliat Care. 2019 Dec; 36(12):1057-1062.
Score: 0.011
-
Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019 03 15; 144(6):1460-1473.
Score: 0.011
-
Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial. Hepatology. 2019 01; 69(1):121-130.
Score: 0.011
-
Social Disadvantage, Healthcare Utilization, and Colorectal Cancer Screening: Leveraging Longitudinal Patient Address and Health Records Data. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1424-1432.
Score: 0.011
-
Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 05; 113(5):746-754.
Score: 0.011
-
Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system. Contemp Clin Trials. 2018 01; 64:77-87.
Score: 0.010
-
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. JAMA. 2017 09 05; 318(9):806-815.
Score: 0.010
-
Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
Score: 0.010
-
Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study. Oncol Nurs Forum. 2017 05 01; 44(3):E101-E110.
Score: 0.010
-
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatology. 2017 04; 65(4):1196-1205.
Score: 0.010
-
Hispanic and Immigrant Paradoxes in U.S. Breast Cancer Mortality: Impact of Neighborhood Poverty and Hispanic Density. Int J Environ Res Public Health. 2016 12 14; 13(12).
Score: 0.010
-
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma. Gastroenterology. 2017 02; 152(3):608-615.e4.
Score: 0.010
-
Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis. Hepatology. 2017 03; 65(3):875-884.
Score: 0.010
-
Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Am J Med. 2017 Jan; 130(1):93.e1-93.e7.
Score: 0.009
-
Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med. 2016 Apr; 31(4):372-9.
Score: 0.009
-
The Desires of Their Hearts: The Multidisciplinary Perspectives of African Americans on End-of-Life Care in the African American Community. Am J Hosp Palliat Care. 2017 Jul; 34(6):510-517.
Score: 0.009
-
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer. 2016 Feb 01; 122(3):456-63.
Score: 0.009
-
Role functioning is associated with survival in patients with hepatocellular carcinoma. Qual Life Res. 2015 Jul; 24(7):1669-75.
Score: 0.008
-
Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med. 2015 Jan; 128(1):90.e1-7.
Score: 0.008
-
Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):791-8.e1.
Score: 0.008
-
Impediments and facilitators to physical activity and perceptions of sedentary behavior among urban community residents: the Fair Park Study. Prev Chronic Dis. 2013 Oct 31; 10:E177.
Score: 0.008
-
Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1101-8.
Score: 0.008
-
Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors. J Cancer Surviv. 2013 Dec; 7(4):624-9.
Score: 0.008
-
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol. 2013 Mar; 108(3):425-32.
Score: 0.007
-
Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv. 2013 Mar; 7(1):155-63.
Score: 0.007
-
Effects of socioeconomic status and health care access on low levels of human papillomavirus vaccination among Spanish-speaking Hispanics in California. Am J Public Health. 2013 Feb; 103(2):270-2.
Score: 0.007
-
Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California. Vaccine. 2012 Apr 19; 30(19):3003-8.
Score: 0.007
-
Understanding impediments and enablers to physical activity among African American adults: a systematic review of qualitative studies. Health Educ Res. 2011 Dec; 26(6):1010-24.
Score: 0.007
-
Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use? Cancer. 2011 Dec 15; 117(24):5450-60.
Score: 0.007
-
Community events as viable sites for recruiting minority volunteers who agree to be contacted for future research. Contemp Clin Trials. 2011 May; 32(3):369-71.
Score: 0.006
-
Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med Care. 2010 Mar; 48(3):249-59.
Score: 0.006
-
Construct validity of a mammography processes of change scale and invariance by stage of change. J Health Psychol. 2010 Jan; 15(1):64-74.
Score: 0.006
-
Mediating factors in the relationship between income and mammography use in low-income insured women. J Womens Health (Larchmt). 2008 Oct; 17(8):1371-8.
Score: 0.005
-
Does patient health and hysterectomy status influence cervical cancer screening in older women? J Gen Intern Med. 2008 Nov; 23(11):1822-8.
Score: 0.005
-
Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2231-7.
Score: 0.005
-
Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter? Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):758-67.
Score: 0.005
-
Promoting regular mammography screening I. A systematic assessment of validity in a randomized trial. J Natl Cancer Inst. 2008 Mar 05; 100(5):333-46.
Score: 0.005
-
Promoting regular mammography screening II. Results from a randomized controlled trial in US women veterans. J Natl Cancer Inst. 2008 Mar 05; 100(5):347-58.
Score: 0.005
-
Reported drop in mammography : is this cause for concern? Cancer. 2007 Jun 15; 109(12):2405-9.
Score: 0.005
-
Test-retest reliability of self-reported mammography in women veterans. Prev Med. 2006 Apr; 42(4):320-6.
Score: 0.005
-
Additive impact of childhood emotional, physical, and sexual abuse on suicide attempts among low-income African American women. Suicide Life Threat Behav. 2002; 32(2):131-8.
Score: 0.003